6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
28m ago	Appendix 4C and Quarterly Activities Report - March 2026
54m ago	Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
54m ago	ING completes share buyback and announces new programme of up to €1.0 billion
55m ago	argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

About

Xeris Pharmaceuticals Inc (NASDAQ:XERS) — investor relations, events, news, and company updates on 6ix.

Latest News

Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026

Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance

Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit

Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026

Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue

Financials

Revenue

$291.84 M

Market Cap

$1.04 B

P/E Ratio

0.00

EPS

0.00

Community Chat

Ask AI